In vitro study demonstrates that ADAM10 restricts HIV-1 propagation by cleaving gp41 in CD4+ T cells, indicating Nef protects viral envelope integrity to maintain infectivity.
HIV-1 Nef enhances virus propagation by down-regulating CD4 and SERINC5. However, recent evidence points to the existence of an additional Nef-sensitive restriction mechanism. We now show that Nef suppresses the aberrant cleavage of HIV-1 gp41 by ADAM10, a virion-associated cellular ectodomain sheddase, and thus increases the amount of HIV-1 envelope glycoprotein (Env) on virions. Additionally, Nef inhibits the shedding of at least some cellular ADAM10 substrates, resulting in their accumulation on HIV-1 virions. Whereas Nef + HIV-1 replicated only marginally better in the absence of ADAM10, the propagation of Nef − HIV-1 was notably rescued in ADAM10 − T cell lines. Crucially, Nef − HIV-1 also benefited from the absence of ADAM10 in primary CD4 + T cells. Collectively, our results indicate that ADAM10 negatively affects both laboratory-adapted and primary HIV-1 strains by shedding the ectodomains of viral and cellular transmembrane proteins from virions and that Nef rescues virus replication by counteracting ADAM10.
No takes yet. Share an insight, caveat, or question.
Olety et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: